We are making the SAS language more accessible and more widely available. Here is how that began, and where our name comes from.
Jenner Analytics began with a clinical trials project. When our founder and CEO, Lawrence W. Sinclair, started working on it, he discovered that much of the SAS code online today relates to clinical trials work.
It brought back his own years with SAS as a consultant, using it for marketing, compliance and financial analysis. Knowing how much the language can do, he set out to make it more accessible and more widely available. That is the work of Jenner Analytics — and the reason for its name.

Jenner Analytics is named after Dr Edward Jenner. Our founder, Lawrence W. Sinclair, is descended from Edward's elder brother, Henry, which makes Dr Jenner his great-uncle seven generations back. The family kept the name: Lawrence's great-grandfather was Edward Jenner Spier, and his grandmother Mona Fanny Jenner Spier.
Edward Jenner (1749–1823) was an English physician and scientist from Berkeley, Gloucestershire. In 1796 he inoculated a young boy, James Phipps, with material from cowpox, and went on to show that the boy was protected from smallpox. His work became the basis of vaccination, and he is often called the father of immunology. The word “vaccine” itself comes from the Latin vacca, meaning cow. Smallpox was declared eradicated in 1980.
It is hard today to picture how much smallpox was feared. In the 18th century it killed an estimated 400,000 people in Europe every year, and in cities such as London it was a common disease of childhood. Between 20% and 60% of those infected died; among infants the rate approached 80% in London and 98% in Berlin. Most survivors were left with disfiguring scars, and smallpox caused about a third of all blindness. Even in the 20th century, before it was eradicated, it killed an estimated 250–500 million people.
The best protection on offer was variolation: deliberately infecting a healthy person with material from a smallpox sore, which was usually far less deadly than catching the disease naturally. Jenner himself was variolated as a boy of about eight, an experience said to have affected his health for the rest of his life. Variolation was far from safe: roughly 1–3% of those treated died, and they could pass smallpox on and start new outbreaks.
Others, such as the farmer Benjamin Jesty in 1774, had already used cowpox to protect their families. Jenner's lasting contribution was to put the idea to the test. Weeks after inoculating James Phipps with cowpox, he exposed the boy to smallpox material, and no disease followed. He repeated the test on further subjects and, when the Royal Society declined his first report in 1797, published 23 cases himself in his Inquiry of 1798: early, careful, systematic testing that showed vaccination to be effective and far safer than variolation.
That evidence carried the argument. By 1800 vaccination had reached most European countries, and in 1840 Britain banned variolation and offered vaccination free of charge. Vaccination went on to become an essential part of the effort that finally rid the world of smallpox.
More than two centuries later, careful trials are still how medicine proves what works.
That discipline lives on in clinical trials, and much of the SAS code online today relates to that work, which is where Lawrence's story began. We carry Jenner's name as a small tribute, with a far more modest ambition of our own: to take something powerful and put it within reach of many more people.

Founder and CEO
Over the last twenty years, Lawrence and his engineering team have helped build more than 150 new technology ventures through his software engineering firm, East Agile.
Before that, he worked in analytics, data science and economics — often using SAS — at Morgan Stanley, Bank of America, Wells Fargo Bank, Intuit, the Bank of Canada (Canada's central bank), the Canadian Department of Finance and Statistics Canada.
He holds an MA in Economics and an MSc in Data Analytics.